Second Day of South Lake Tahoe Racing on Tap for Tomorrow Before the Peloton Turns toward Elk Grove and Sacramento
LOS ANGELES, Calif. (May 11, 2017) – For the second year running, Boels-Dolmans Cycling Team’s three-time U.S. National Champion Megan Guarnier mounted a remarkable climb to a first-place finish at day one of the Amgen Breakaway from Heart Disease™ Women’s Race empowered with SRAM. The result came down to the final climb just as it did on the same South Lake Tahoe route last year, when California’s Bay Area-based Guarnier took the stage and went on to become the overall race champion.
Guarnier is working back from a concussion suffered earlier this season, making today’s victory even more sweet: “They (Guarnier’s teammates) had their work cut out for them today, it was quite aggressive, and they had to keep things together, or be in the breaks&hellips; they just let me stay calm and save everything for the finish,” said Guarnier.
The Amgen Breakaway from Heart Disease™ Women’s Race empowered with SRAM kicked off its second year on the UCI Women’s WorldTour when the four-day stage race began in South Lake Tahoe today. The stage, presented by Breakaway from Heart Disease™, began and ended at Heavenly Mountain Resort, featuring two sprints, 5,300’ of elevation gain and two Queen of the Mountain (QOM) climbs. The final climb of the day saw the peloton riding together and working to ensure good positioning for their lead riders contending for the overall win. The final meters saw an attack from Boels-Dolmans’ 2016 Olympic Games road race gold medalist Anna van der Breggen (NED), who came away with second place today after helping boost teammate Guarnier to the line.
Early breaks by Cylance Pro Cycling’s Alison Tetrick (Petaluma, Calif.) and then by two national champions – Mexico’s Ingrid Drexel (Team TIBCO - Silicon Valley Bank) and New Zealand’sRushlee Buchanan (UnitedHealthcare Pro Cycling) – were reeled in by a thundering peloton.
As Hagens Berman | Supermint and Boels-Dolmans worked to bring the group back together, Hagens’ Australian rider Lizzie Williams took off the front and grew her solo lead to one minute before being reabsorbed on a climb with just under 30 km to go, coming away with the Breakaway from Cancer® / Breakaway from Heart DiseaseTM Most Courageous Rider Jersey.
Tomorrow’s Stage 2 presented by Visit California is an all-new 67-mile route again hosted in South Lake Tahoe that will include the first Amgen Tour of California climb up the infamous Kingsbury Grade, an 8-mile climb that gains 2,700’ in elevation.
The Amgen Breakaway from Heart Disease™ Women’s Race empowered with SRAM is one of the biggest platforms in the world for women’s cycling, featuring 17 teams and 95 premier cyclists. The women will contest a 256.6-mile course during the 2017 four-stage event.
“Today was an all-star celebration of professional women’s cycling and the incredible level of competition and skill the riders now showcase,” said Kristin Klein, race president and executive vice president of AEG Sports.
Stage 1 Podium
1. Megan Guarnier (USA), Boels-Dolmans Cycling Team (NED)
2. Anna van der Breggen (NED), Boels-Dolmans Cycling Team (NED)
3. Arlenis Sierra (CUB), Astana Women’s Team (KAZ)
Stage 1 Jersey Winners
A biotechnology company in the race to dramatically improve patients’ lives, Amgen is steadfastly focused on a single mission: developing medicines to help patients with serious illness such as cancer, cardiovascular disease, rheumatoid arthritis, bone disease, kidney disease and neurological disorders.
Amgen is raising awareness of heart disease by leveraging its sponsorship of the Amgen Breakaway from Heart Disease™ Women's Race empowered with SRAM to encourage Americans to take charge of their risk of heart disease and feel empowered to take action for good heart health.
Breakaway from Heart Disease™ encourages Americans to take charge of their risk of heart disease and represents a partnership between Amgen and the American Heart Association. The initiative is dedicated to empowering everyone to take action for good heart health through diagnostic screenings, courtesy of the American Heart Association, as well as providing information and tools related to physical activity and healthy eating. Amgen also has a partnership with the bike company Schwinn to encourage heart-healthy activities like bike riding.
Throughout the women’s race, local community members who are living with heart disease will participate in the official start ceremonies as well as award the dailyBreakaway from Heart Disease™ Most Courageous Rider jersey, given to the athlete whose performance best exemplifies the character of those engaged in the fight against their disease. The jersey celebrates the athlete’s courage, tenacity, inspiration, optimism and resolve.
About the Amgen Tour of California
The Amgen Tour of California is a Tour de France-style cycling road race created and presented by AEG that challenges the world's top professional cycling teams to compete along a demanding course that traverses hundreds of miles of California's iconic highways, byways and coastlines each spring. The teams chosen to participate have included Olympic medalists, Tour de France contenders and World Champions, and awards important, world-ranking points to the top finishers. More information is available at amgentourofcalifornia.com.
The first-ever U.S. UCI WorldTour course will cover more than 583 miles through 12 Host Cities May 14-20, including Sacramento, Modesto, San Jose, Pismo Beach, Morro Bay, Santa Barbara, Santa Clarita, Ontario, Mt. Baldy, Big Bear Lake, Mountain High and Pasadena. The Amgen Breakaway from Heart DiseaseTM Women's Race empowered with SRAM May 11-14 will cover 256.6 miles through South Lake Tahoe, Elk Grove and Sacramento, concluding as the men’s race gets underway.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Headquartered in Los Angeles, California, AEG is the world's leading sports venue and live entertainment company. With offices on five continents, AEG operates in the following business segments: AEG Facilities, which is affiliated with or owns, manages or consults with more than 120 preeminent arenas, stadiums, theaters, clubs and convention centers around the world including The O2 Arena, the Sprint Center and the Mercedes-Benz Arenas; AEG Live, which is dedicated to all aspects of live contemporary music performances, including producing and promoting global and regional concert tours, music and special events and world-renowned festivals; AEG Real Estate, which develops world-class venues, as well as major sports and entertainment districts like STAPLES Center and L.A. LIVE; AEG Sports, which is the world's largest operator of sports franchises and high-profile sporting events; and AEG Global Partnerships, which oversees worldwide sales and servicing of sponsorships including naming rights, premium seating and other strategic partnerships. Through its worldwide network of venues, portfolio of powerful sports and music brands and its integrated entertainment districts, AEG entertains more than 100 million guests annually. More information about AEG can be found at www.aegworldwide.com.
# # #
Michael Roth, AEG
Josh Levitt, Canvas Blue